Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

Presentation TCT 2023

Optimal Antithrombotic Strategies in MCS Use

Presenter: Mirvat Alasnag

October 26, 2023

Presentation TCT 2023

Con: Favorable Data Is Lacking on MCS in AMI Cardiogenic Shock (Randomized Data Are Needed)

Presenter: Sanjit Jolly

October 24, 2023

Presentation TCT 2023

Pro: Most Patients With AMI Cardiogenic Shock Should Get MCS (Randomization Is Unethical)

Presenter: William O'Neill

October 24, 2023

Presentation TCT 2023

TCT 740: Multidisciplinary Team Approach to Reducing Vascular Complications in MCS Impella Support Patients

Presenter: Haroon Faraz

October 24, 2023

Presentation TCT 2023

My Top 5 Most Critical Clinical and Technology Needs in Temporary MCS

Presenter: Nicolas Van Mieghem

October 23, 2023

Presentation TCT 2022

Percutaneous MCS Support for PCI in Surgically Ineligible Patients: Preliminary Results from Optimum

Presenter: Adam Salisbury

September 18, 2022

Presentation TCT 2022

MCS Initiation - Fuel Injection or Plug In the Pump?: Pharmacological vs. Mechanical Support

Presenter: Jeffrey Shih

September 16, 2022

Presentation TCT 2022

Impella Regret: Case-based Advancement in MCS Decision-Making and Execution

Presenter: Nathan Masterson

September 16, 2022

News Conference News TCT 2021

Mortality High in Patients With STEMI, COVID-19 on Hemodynamic Support

Caitlin E. Cox

November 11, 2021

News Conference News TCT 2020

Trickier Patients, Fewer Adverse Events in High-risk PCI: Impella PROTECT III Registry

Caitlin E. Cox

October 18, 2020

Presentation TCT 2020

The Role of MCS Is Anything but Proven!

Presenter: Sunil Rao

October 14, 2020

Presentation TCT 2020

Hemodynamic Profile of Different MCS Devices

Presenter: Daniel Burkhoff

October 14, 2020

News Conference News TCT 2019

NCSI Strategy for Acute MI Cardiogenic Shock Reaps Better Survival

Caitlin E. Cox

October 10, 2019

News Conference News TCT 2019

In-Hospital Mortality Hasn’t Budged Despite Changes in MCS for Cardiogenic Shock

Caitlin E. Cox

October 04, 2019

News Conference News TCT 2019

Strokes Increasing in STEMI Patients With Cardiogenic Shock

Todd Neale

September 25, 2019

Presentation TCT 2018

Case Presentation #3: STEMI With Cardiogenic Shock and No Simple Options for MCS

Presenter: Vladimir Dzavik, Richard Smalling, Ramesh K. Adiraju, Nicola Corvaja, Vasim Farooq, Sanjog Kalra, Barry D. Rutherford, Marco V. Wainstein

September 24, 2018

News Conference News TCT 2017

Massive Study Offers Snapshot of PCI Outcomes in Nonagenarians

Ashley Lyles

November 06, 2017

News Conference News TCT 2016

Impella CP Fails to Show Benefit in Exploratory Study of Patients With Severe Cardiogenic Shock

Todd Neale

October 29, 2016

Advertisement

Optimal Antithrombotic Strategies in MCS Use

Con: Favorable Data Is Lacking on MCS in AMI Cardiogenic Shock (Randomized Data Are Needed)

Pro: Most Patients With AMI Cardiogenic Shock Should Get MCS (Randomization Is Unethical)

TCT 740: Multidisciplinary Team Approach to Reducing Vascular Complications in MCS Impella Support Patients

My Top 5 Most Critical Clinical and Technology Needs in Temporary MCS

Percutaneous MCS Support for PCI in Surgically Ineligible Patients: Preliminary Results from Optimum

MCS Initiation - Fuel Injection or Plug In the Pump?: Pharmacological vs. Mechanical Support

Impella Regret: Case-based Advancement in MCS Decision-Making and Execution

Mortality High in Patients With STEMI, COVID-19 on Hemodynamic Support

Trickier Patients, Fewer Adverse Events in High-risk PCI: Impella PROTECT III Registry

The Role of MCS Is Anything but Proven!

Hemodynamic Profile of Different MCS Devices

NCSI Strategy for Acute MI Cardiogenic Shock Reaps Better Survival

In-Hospital Mortality Hasn’t Budged Despite Changes in MCS for Cardiogenic Shock

Strokes Increasing in STEMI Patients With Cardiogenic Shock

Case Presentation #3: STEMI With Cardiogenic Shock and No Simple Options for MCS

Massive Study Offers Snapshot of PCI Outcomes in Nonagenarians

Impella CP Fails to Show Benefit in Exploratory Study of Patients With Severe Cardiogenic Shock

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content